Efficient production of Cre-mediated site-directed recombinants through the utilization of the puromycin resistance gene, pac: A transient gene-integration marker for ES cells (original) (raw)
Journal Article
,
1
Department of Morphology, Institute for Developmental Research, Aichi Human Service Center
,
Kamiya-cho, Kasugai, Aichi 480-03, Japan
Search for other works by this author on:
,
Laboratory of Neurobiology and Behavioral Genetics, National Institute for Physiological Sciences
,
Myodaiji, Okazaki 444, Japan
Search for other works by this author on:
,
Laboratory of Neurobiology and Behavioral Genetics, National Institute for Physiological Sciences
,
Myodaiji, Okazaki 444, Japan
Search for other works by this author on:
,
1
Department of Morphology, Institute for Developmental Research, Aichi Human Service Center
,
Kamiya-cho, Kasugai, Aichi 480-03, Japan
Search for other works by this author on:
,
Laboratory of Neurobiology and Behavioral Genetics, National Institute for Physiological Sciences
,
Myodaiji, Okazaki 444, Japan
Search for other works by this author on:
Laboratory of Neurobiology and Behavioral Genetics, National Institute for Physiological Sciences
,
Myodaiji, Okazaki 444, Japan
*To whom correpondence should be addressed. Tel: +81 564 55 7744; Fax: +81 564 55 7741; Email: yagi@nips.ac.jp
Search for other works by this author on:
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
Received:
23 October 1997
Accepted:
25 November 1997
Published:
01 January 1998
Cite
Masahiko Taniguchi, Makoto Sanbo, Satoshi Watanabe, Ichiro Naruse, Masayoshi Mishina, Takeshi Yagi, Efficient production of Cre-mediated site-directed recombinants through the utilization of the puromycin resistance gene, pac: A transient gene-integration marker for ES cells, Nucleic Acids Research, Volume 26, Issue 2, 1 January 1998, Pages 679–680, https://doi.org/10.1093/nar/26.2.679
Close
Navbar Search Filter Mobile Enter search term Search
Abstract
Gene targeting in embryonic stem (ES) cells is a powerful tool for generating mice carrying specifically designed mutations in the germline. Puromycin can completely kill ES cells within 24 to 48 h whereas G418 and hygromycin cannot. We have, therefore, proposed that the puromycin N-acetyltransferase (pac) gene, may be utilized as a transient gene-integration marker. Using a circular expression vector of cre and pac genes, Cre-mediated mutant cells were effectively enriched by pulse treatment of puromycin without stable integration of their genes. We have thus demonstrated the first application of pac as a transient gene-integration marker for ES cells.
Puromycin can effectively kill ES cells within a short period (2 days) and at a low dose, independent of G418 selection. The low dose of puromycin, which effectively eliminates wild-type ES cells, has little influence on the feeder cells from mouse embryonic fibroblasts, enabling the use of wild-type feeder cells for puromycin selection. The puromycin selected ES cells effectively colonized into germ cells in chimeric mice (1). Because the time course profile for puromycin to kill ES cells is different from that of other drugs such as G418 and hygromycin, the puromycin-pac gene system may be utilized not only in producing stable integrants, but also for the selection of transient transgene integrants.
To evaluate selectional efficiency for transient pac gene integrants, we used the Cre-mediated loxP recombination system, as no gene markers remain in the chromosome of transient gene integrants. Transient expression of the cre gene is employed for the acquisition of Cre-_loxP_-mediated recombinants without other chromosomal DNA damages. This system promotes gene disruption between two loxP sites through the transient expression of Cre recombinase. Using this method for ES cells allows us to produce various specifically designed mutant mice (2,3). To enrich for Cre-_loxP_-mediated recombinants in ES cells, Gu et al. used supercoiled Cre-encoding plasmid to transiently express the Cre enzyme, followed by selection with Gancyclovir (GANC) to eliminate cells containing the stable herpes simplex virus-thymidine kinase (HSV-tk) gene, which was located within the flanking DNA region between the loxP sites (4).
Figure 1
Recombination using pCre-Pac plasmid. Strategy for recombination using pCre-Pac plasmid. (plasmid) Closed circular pCre-Pac DNA is transfected by electroporation into ES cells containing two loxP sites. (ii) Transfected pCre-Pac DNA expressing Cre and Pac products. (iii) Cre protein recognizes the loxP sites and recombines between these sites. ES cells are selected by puromycin at (ii) and (iii) periods. (iv) Cre-mediated recombination between loxP sites is complete in ES cells. The chromosome containing a single loxP site and excised circular DNA containing a single loxP site are lost. The 1.7 kb _Sal_I fragment from pPGKPuro was ligated into the 4.3 kb _Xho_I-_Sal_I fragment from pPGKPuro was ligated into the 4.3 kb _Xho_I-_Sal_I fragment from pMC1-Cre (5) to yield pCre-Pac.
The experimental strategy is outlined in Figure 1. To test this, we constructed a circular pCre-Pac plasmid which coincidentally expressed both the pac and cre genes in ES cells, and obtained a gene-targeted cell line; clone-121, containing three loxP sites at the mouse semaphorin III/D locus (5). The enrichment of Cre-mediated recombinants at the loxP sites by transient puromycin selection was determined by electroporating the circular pCre-Pac plasmid into clone-121; thereafter we altered the time-course of puromycin selection. In experiments, we transiently administered 1 µg/ml puromycin during 24 or 48 h at several time-courses (Table 1). To separate a single type of recombinant, we subcultured the transformants on new feeder cell layers after pulse selection by puromycin. After six days with normal ES cell medium, we analyzed the Cre-_loxP_-mediated recombinants by PCR and Southern blot analyses. Since clone-121 contained three tandem loxP sites which was located at the 5′ non-coding region of the first exon and both edges of lacZ-neo cassette at the first intron of the semaphorin III/D locus (5), three types of site-directed recombinants were generated: type-1, −2 or −3 deletions resulted, respectively, in the following phenotypes: null, the deletion of both the firstexon and the lacZ-neo cassette; conditional, the deletion of the external _lacZ_-neo cassette; or ‘knocked-in’ lacZ gene, the deletion of the first exon. These deletion types were firstly detectable by PCR analyses (data not shown). Cre-loxP mediated recombinants were from 9.4 to 63% of the surviving single-genotype cells after puromycin selection at various time courses (Table 1). At the time course of 6–54 h in experiment 2 or 3, we could obtain all three type recombinants at 39% (29/75). Among these 29 recombinants, 24, 3 and 2 were identified as type-1, −2 and −3, respectively. Since 1.4 and 10 × 102 clones arose by pulse selection with puromycin from 6 to 54 h in contrast to 1.5 and 4.8 × 104 clones without the puromycin, the pulse selection of puromycin enriched transient-transgene integrants 50–100-fold. In previous reports on the selection of Cre-mediated recombinants by the HSV-tk gene and GANC, ∼20% of the GANC-selected colonies resulted from the site-directed recombination (4). This evidence indicates that our Cre-loxP recombination system is a more efficient method for the enrichment of recombinants in comparison to other drugs. However, 83% (24/29) of the site-directed recombinants were type-1 at the 6–54 h time course. This type-1 distortion suggests that the activity of Cre with this puromycin-pac system may be too high to limit site-directed recombination at a single event. To efficiently enrich for type-2 or −3 recombinants, an attempt should be made to use a weaker promoter of cre gene or less activity of Cre enzyme.
Table 1
Frequency of recombination by pCre-Pac plasmid
After the three types of site-directed recombinants were confirmed by Southern blot analyses (data not shown), we chose every one clone for each type of recombinants; 121-12-22 (type-1), 121-48-55 (type-2) and 121-48-26 (type-3), and produced chimeric mice. Neither the pac nor cre gene was detectable by PCR and Southern blot analyses (data not shown). Ten of each ES cell-line were microinjected into an 8-cell stage CD-1 mouse embryo (6). The microinjected embryos were cultured in M16 medium overnight to blastocyst stage. Seven blastocysts were transplanted into each uterus of recipient CD-1 mice. Chimeric mice were identified by eye and coat colors and germline transmission was confirmed by coat color of offspring with crossing with CD-1 females. One chimeric male from parental clone-121 was obtained with an agouti coat color of >80%, which exhibited a germline-differentiating potency when mated with albino CD-1 females (5). In contrast, 8, 4 and 5 chimeric males obtained by microinjection with type-1, −2 and −3 recombinants, respectively, into CD-1 embryos had >80% agouti hair color. By crossing these chimeric mice with CD-1 females, 3, 1 and 2, respectively, produced ES-cell derived offspring. All types of Cre-mediated recombinants thus maintained the germline-differentiating potency. Cre-mediated recombinants possessed similar or even greater potency in comparison to the parental clone-121 cell to differentiate each tissue and germ cell in chimeric mice. These results indicated that neither pulse selection of puromycin nor Cre and/or Pac transient expression influenced the stability of germline-differentiating potency in ES cell culture.
Instead of this pac gene, GFP gene can also be used for selecting Cre recombinants (7). Nevertheless these results establish the applicability of the puromycin-pac gene system as a novel selection system for transient extragene integrants, and demonstrate a highly efficient and facile method for screening Cre-mediated site-directed recombinants of ES cells with strong germline differentiating potency. This method is based on the transient integration of a circular pCre-Pac plasmid, which allows selection of transient expression of Cre recombinase by short puromycin exposure. These results indicate that transient Pac expression allows us to select and enrich the transient gene integrants with puromycin. Thus, this is a first selection marker for transient gene integration.
Acknowledgments
We thank Peter W.Laird for the gift of pPGKPuro and H.Gu and K.Rajewsky for the gift of pL2-Neo and pMC1Cre. This research was supported by a grant from the Japanese Ministry of Education, Science and Culture, the Nissan Foundation, and CREST (Core Research for Evolutional Science and Technology) of Japan Science and Technology Corporation (JST).
References
1
et al. ,
Biochem. Biophys. Res. Commun.
,
1995
, vol.
213
(pg.
130
-
137
)
2
et al. ,
Nature
,
1995
, vol.
378
(pg.
720
-
724
)
3
et al. ,
Nature Genet.
,
1995
, vol.
9
(pg.
376
-
385
)
4
et al. ,
Cell
,
1993
, vol.
73
(pg.
1155
-
64
)
5
et al. ,
Neuron
,
1997
, vol.
19
(pg.
519
-
530
)
6
et al. ,
Anal. Biochem.
,
1993
, vol.
214
(pg.
70
-
76
)
7
et al. ,
Nucleic Acids Res.
,
1997
, vol.
25
(pg.
3326
-
3331
)
Author notes
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
© 1998 Oxford University Press
I agree to the terms and conditions. You must accept the terms and conditions.
Submit a comment
Name
Affiliations
Comment title
Comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.
Citations
Views
Altmetric
Metrics
Total Views 1,469
1,157 Pageviews
312 PDF Downloads
Since 1/1/2017
Month: | Total Views: |
---|---|
January 2017 | 5 |
February 2017 | 12 |
March 2017 | 10 |
April 2017 | 4 |
May 2017 | 15 |
June 2017 | 6 |
July 2017 | 4 |
August 2017 | 3 |
September 2017 | 3 |
October 2017 | 6 |
November 2017 | 11 |
December 2017 | 19 |
January 2018 | 12 |
February 2018 | 15 |
March 2018 | 15 |
April 2018 | 12 |
May 2018 | 20 |
June 2018 | 11 |
July 2018 | 21 |
August 2018 | 22 |
September 2018 | 17 |
October 2018 | 11 |
November 2018 | 17 |
December 2018 | 19 |
January 2019 | 19 |
February 2019 | 20 |
March 2019 | 15 |
April 2019 | 29 |
May 2019 | 22 |
June 2019 | 25 |
July 2019 | 15 |
August 2019 | 17 |
September 2019 | 14 |
October 2019 | 13 |
November 2019 | 28 |
December 2019 | 15 |
January 2020 | 14 |
February 2020 | 15 |
March 2020 | 15 |
April 2020 | 16 |
May 2020 | 4 |
June 2020 | 20 |
July 2020 | 9 |
August 2020 | 6 |
September 2020 | 20 |
October 2020 | 11 |
November 2020 | 23 |
December 2020 | 11 |
January 2021 | 7 |
February 2021 | 19 |
March 2021 | 23 |
April 2021 | 35 |
May 2021 | 42 |
June 2021 | 25 |
July 2021 | 16 |
August 2021 | 10 |
September 2021 | 20 |
October 2021 | 19 |
November 2021 | 19 |
December 2021 | 16 |
January 2022 | 16 |
February 2022 | 28 |
March 2022 | 21 |
April 2022 | 16 |
May 2022 | 19 |
June 2022 | 11 |
July 2022 | 17 |
August 2022 | 27 |
September 2022 | 19 |
October 2022 | 17 |
November 2022 | 20 |
December 2022 | 12 |
January 2023 | 12 |
February 2023 | 10 |
March 2023 | 13 |
April 2023 | 13 |
May 2023 | 12 |
June 2023 | 15 |
July 2023 | 12 |
August 2023 | 11 |
September 2023 | 13 |
October 2023 | 6 |
November 2023 | 19 |
December 2023 | 12 |
January 2024 | 22 |
February 2024 | 12 |
March 2024 | 7 |
April 2024 | 20 |
May 2024 | 17 |
June 2024 | 23 |
July 2024 | 19 |
August 2024 | 15 |
September 2024 | 15 |
October 2024 | 11 |
Citations
86 Web of Science
×
Email alerts
Citing articles via
More from Oxford Academic